局部前列腺癌的常規治療選擇包括前列腺切除術、放射治療及積極監測。然而，前列腺切除術及放射治療均有一定程度的併發症，包括尿失禁、勃起功能障礙及鄰近結構損傷的風險。積極監測則帶有疾病惡化及患者心理困擾的風險。
適應症：Prostate Cancer
收案條件
納入條件
- Visible index lesion(s) on MRI
- Index lesion(s) greater than 0.5 cm3
- Found to have localized low-risk or intermediate-risk prostate cancer after MRI-USG fusion targeted biopsy and saturation biopsy:
- Clinical tumour stage T2, or
- Gleason score 7, or
- PSA 20 ng/ml
排除條件
- Prostate size larger than 50 ml
- Patients unfit for contrast MRI exam
- Patients with previous treatment of prostate cancer
- Patients with previous surgery on the prostate
- Patients with active urinary tract infection
- Patients with bladder pathology including bladder stone and bladder cancer
- Patients with urethral stricture
- Patients with neurogenic bladder and/or sphincter abnormalities
- Fail to give informed consent
收案條件維持 ClinicalTrials.gov 原始英文登錄資料，實際收案資格以研究團隊的正式評估與受試者同意書為準。資料來源：ClinicalTrials.gov，每兩週自動更新，最後同步：2026年11月5日。